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abstract 
background: Chronic plaque psoriasis is an inflammatory skin condition that affects up to 3% of 
the UK population and most patients have mild to moderate disease that can be effectively managed 
with topical therapies in primary care. In recent years, community pharmacists in the UK have been 
encouraged to adopt a more clinically focused role, particularly around supporting those with long-
term conditions. However, little is known about how pharmacists might help support those with long-
term skin conditions.
objectives: To determine patient and participating pharmacists’ views of an educational intervention 
delivered in community pharmacy to those with mild to moderate chronic plaque psoriasis.
Methods: Pharmacists recruited patients either opportunistically when they presented at the 
pharmacy with a prescription for psoriasis treatment, or via a letter of invitation to those identified from 
their pharmacy medication records as using prescribed topical treatment for psoriasis. The intervention 
consisted of one face-to-face consultation and a follow-up appointment after approximately 6 weeks. 
Structured telephone interviews were conducted with 38 of the patients who participated in the 
intervention after completion of the follow-up visit. The interviews sought information on patients’ 
reasons for joining the study, measures of satisfaction with the pharmacy consultation and perceptions 
on whether the pharmacist’s advice improved their skin condition. The data generated were analysed 
quantitatively with open responses coded for subsequent analysis.
In addition, semi-structured telephone interviews conducted with all seven participating pharmacists, 
explored their perceptions on the value of the intervention for both themselves and patients and 
the potential for wider adoption of such a service. All interviews were audio-recorded, transcribed 
verbatim and analysed thematically.
results: Nearly three-quarters of patients (74%) joined the study to learn more about their condition 
and its management and half, (51%) reported improvements in knowledge after the intervention. The 
majority (84%) of patients believed that their psoriasis had improved as a result of the advice they 
received during the intervention.
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Pharmacists also improved their knowledge of psoriasis and its management and welcomed the 
opportunity for greater patient interaction, believing that patients benefited from the intervention and 
saw pharmacists as members of the healthcare team managing their condition. However, ensuring 
patients returned for the second appointment and juggling the demands of the study with other work 
was sometimes problematic. There were mixed views on the wider adoption of the intervention.
conclusion: In the present study, patients felt that their psoriasis improved as a result of the advice 
from pharmacists and this view was shared by pharmacists. further work with a larger patient cohort 
is necessary to explore the extent to which these findings are generalisable to the wider population of 
pharmacists and patients with mild to moderate psoriasis. 
introduction 
Plaque psoriasis is a chronic inflammatory skin condition that is thought to affect up to 3% of  the 
UK population1. Though not life-threatening, psoriasis it is associated with a significant impairment 
of  quality of  life2 and emotional well-being3. Most patients with plaque psoriasis have mild to 
moderate disease which can be managed with topical therapies in primary care4. Nevertheless, 
adherence to topical regimes is often poor5,6. Furthermore, qualitative studies in those with psoriasis 
have revealed an often erratic and inconsistent use of  topical therapies, a desire for advice on 
the correct use of  topical therapies (which is usually absent in consultations) and a perception 
that healthcare professionals lack sufficient knowledge and expertise of  psoriasis7-9. Consequently, 
patients frequently sub-optimally manage their condition often in isolation from healthcare 
professionals due to the absence of  adequate advice on treatments. These studies clearly illustrate 
the need for more effective community based information, education and support for those with 
psoriasis. 
Educational interventions for those with a skin problem aim to lessen the impact on quality of  life 
and reduce disease severity and there is some evidence that adjunctive patient education for those 
with skin problems such as atopic eczema, leads to improvements in disease outcomes10. However, 
recently, it was concluded that educational interventions for patients with psoriasis employed in 
clinical trials have met with limited success with respect to improving disease severity and quality 
of  life11.
Previous studies suggest that educational input by pharmacists is beneficial in the management 
of  hypertension and diabetes, though results are mixed for other medical conditions12. There is a 
paucity of  data on the role of  community pharmacists in the management of  patients with long-
term skin conditions except for one small pilot study in 50 children with atopic eczema. This study, 
though uncontrolled and limited by sample size, did find that educational advice on the use of  
emollients given to the parents of  children with atopic eczema, produced a small, but statistically 
significant reduction in itch and irritability13.
In a recent uncontrolled study, we demonstrated that an educational intervention by community 
pharmacists to patients with psoriasis, appeared to improve knowledge, disease severity and quality 
©SelfCAre 2016
19
PATIeNT ANd PHArmACIST PerCePTIoNS of A PHArmACIST-led edUCATIoNAl INTerveNTIoN for PeoPle WITH PSorIASIS
of  life14. In this paper, we explore the perceptions of  the patients and participating pharmacists 
from that study.
The aims of  the study were to:
•	Explore	patient	views	of 	the	pharmacist	consultation
•	To	explore	patients’	views	of 	the	impact	of 	the	intervention	on	their	condition	
•	Examine	pharmacists’	perceptions	on	the	delivery	of 	the	intervention.	
Materials and Method 
Design and setting
The study was conducted in a total of  seven community pharmacy sites in the South West of  
England and Yorkshire and Humber (Eastern England). The local clinical research networks 
(CRNs) were approached to help identify pharmacists who had registered an interest in undertaking 
research work (and had completed good clinical practice training) to participate in the study.
Patients were recruited either opportunistically when presenting at the pharmacy with a prescription 
for psoriasis treatment or via a letter of  invitation sent by the pharmacist to those prescribed topical 
treatments for psoriasis identified through the pharmacy computer system records. Pharmacists 
gained informed consent and enrolled patients into the study. As a part of  the consent process, 
patients provided telephone details and suitable times (a.m. or p.m.) to allow them to be contacted 
by a researcher at a later stage for a follow-up interview.  
Intervention
The details of  the intervention have been described elsewhere14. In brief, pharmacists conducted 
one face-to-face consultation with patients and a follow-up visit approximately 6 weeks later and 
used the person-centered dermatology self-care index (PEDESI)15,	 to	assess	 individual	patient’s	
educational and support needs. This instrument is designed to explore various aspects of  a 
patient’s	knowledge	about	their	skin	condition	and	its	management	including	possible	triggers,	the	
role of  prescribed treatments, adverse effects etc. The pharmacists then provide tailored advice 
to	 enhance	 a	 patient’s	 level	 of 	 understanding	of 	 each	 topic.	 In	 the	 study,	 disease	 severity	 and	
quality of  life were assessed prior to the consultation using the self-assessed psoriasis and severity 
index (SAPASI)16 and the dermatology quality of  life index (DLQI)17 respectively. At the follow-up 
appointment all three measures (PEDESI, SAPASI and DLQI) were re-assessed. 
Patient interviews
Structured telephone interviews were conducted with patients after completion of  the follow-up 
appointment by one of  us (RT). The questions captured data on gender, age, the length of  time 
(in years) that patients had suffered with psoriasis and included several questions on consultation 
satisfaction which were based on an instrument derived from a validated scale developed for 
general practitioners18. Participants provided verbal consent to have the telephone interview 
audio-recorded and in conducting the telephone interviews, the researcher read the questions 
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and potential answers to participants and recorded their answer. For open ended questions, i.e., in 
describing what participants liked most and least about the intervention and any further comments, 
responses were transcribed verbatim and coded into categories which were then quantified and 
independently checked by both authors.
The questions were piloted with one patient who revealed no problems and who was subsequently 
included in the final analysis. 
Pharmacist interviews
All participating pharmacists provided informed and written consent to participate in semi-
structured telephone interviews which were conducted by the same researcher (RT) and arranged 
at a mutually convenient time after completion of  the patient follow-up appointments. The topic 
guide for the interviews is shown in Table 1.
table 1: topic guide for the pharmacist interviews  
•	 	How	much	did	you	know	about	psoriasis	before	undertaking	the	study?	
•	 	What	are	the	main	things	that	you	have	learnt	about	psoriasis	from	doing	the	study?
•	 	What	were	the	things	that	you	liked	about	the	study?	Was	there	anything	that	you	
disliked?
•	 	What	if	anything,	were	the	main	problems	in	providing	the	service?	How	might	these	
problems	be	overcome?
•	 	How	do	you	think	customers	viewed	your	role	in	relation	to	the	management	of	their	
psoriasis	as	a	result	of	the	study?
•	 Do	you	feel	that	the	service	was	of	value	to	patients?	In	what	ways?	
•	 	Do	you	think	that	the	intervention	could	become	a	model	for	an	enhanced	service	in	
pharmacies?	
Analysis
Responses to the patient interviews were entered into SPSS (SPSS Inc., Cary, NC version 21.0) and 
analysed descriptively. Comments to open questions were coded in SPPS. 
The pharmacist interviews were transcribed verbatim and analysed thematically using Nvivo (QSR 
International Pty Ltd. Version 10, 2014).
results
Patient characteristics
In total 42 patients completed the two consultations, though only 38 (20 males and 18 female) 
patients were contactable for the follow-up interview. Reasons for lack of  contact included incorrect 
telephone numbers and failure to respond to answerphone messages. 
The mean age of  interviewed participants was 61 years (± 16.9) compared to the overall sample 
mean of  59 years, with a range of  69 years. The youngest participant was 21 and the oldest 90 
years of  age. Interviewed participants had suffered with psoriasis for a mean of  24 years (± 17.9) 
with a range of  65 years.
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Patient interviews
Patients’	 reasons	 for	 joining	 the	 study,	 most	 favourable	 aspects	 of 	 the	 consultations	 and	 their	
perceptions on whether the advice/information received improved their skin condition are shown 
in Table 2. The level of  agreement with several aspects related to patient satisfaction with the 
pharmacist consultation are shown in Table 3. 
table 2: Participant perceptions of the intervention
reasons for participating in the study*
wanted more information about psoriasis and 
treatment
concerned about their psoriasis
invited to join the study
Aspects	of	the	study	most	liked	by	participants*
Improved	knowledge	of	condition	and	treatment
one-one interaction
advice on emollient use 
nothing
Do	you	think	your	psoriasis	improved	as	a	result	
of	the	pharmacist’s	advice?
Yes
no
not sure
                
 N    %
42
7
8
33
21
7
3
32
4
2
74
12
14
51
33
11
5
84
11
5
*participants could give more than one answer
table 3: level of agreement with statements
statements*
i understand my psoriasis much better after 
seeing the pharmacist
the pharmacist told me everything about my 
treatments
i am happy with the length of time i spent with 
the pharmacist
the follow-up visit was beneficial to me
i am totally satisfied with my visits to the 
pharmacist
some things about my consultation could have 
been better
i would recommend this service to others
 median
 score
4.00
5.00
5.00
5.00
5.00
2.00
5.00
IQr
2.00
1.00
0.75
1.00
0.00
0.00
0.00
N
38
38
38
36
38
38
38
*Based	on	a	5-point	Likert	scale	(1	=	strongly	disagree,	5	=	strongly	agree)
		IQR	=	Interquartile	range.	Cronbach’s	alpha	=	0.74
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Pharmacist interviews
All seven pharmacists involved in the study participated in follow-up semi-structured telephone 
interviews. The pharmacist characteristics are shown in Table 4. 
Table	4:	Pharmacist	and	Pharmacy	characteristics
gender
Male
Male
Male
Male
female
Male
female
age
29
30
40
38
39
48
37
Years 
qualified
29
30
40
38
39
48
37
Pharmacist 
code
Ph1
Ph2
Ph3
PH4
Ph5
Ph6
Ph7
Pharmacy type
suburban
(Independent)
rural
(Independent)
rural
(Independent)
suburban
(Multiple)
urban
(Multiple)
rural
(Independent)
suburban
(Independent)
What did pharmacists know about psoriasis before the study? 
The key theme with respect to prior knowledge was how little pharmacists knew about the 
condition before undertaking the study. With the exception of  two pharmacists (one had created a 
local training guide and another who suffered with guttate psoriasis) none of  the others knew much 
about the condition as one pharmacist reflected:
“It wasn’t something that I probably had an in-depth knowledge of… I knew the basics that it was thickening 
of  the skin but didn’t really understand what was causing that thickening … and how the treatments 
worked.” [PH4]
This view was echoed by another:
“I didn’t have a special interest in it, I had obviously done dermatology lectures as an undergraduate and 
I’ve done a few bits of  CPD since qualifying… but before I did the study I didn’t really have a decent 
knowledge on it.” [PH2]
What have pharmacists learnt about psoriasis from undertaking the study?
The main theme to emerge was an enhanced understanding of  psoriasis with three sub-themes 
which were:
•	 Impact on patients
•	Greater	treatment	knowledge
•	 Improved	confidence
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Impact on patients
One pharmacist remarked on how he now had a greater insight into the psychological impact of  
the condition: 
“[I’ve learnt] more about the impact on life … how it takes over routines. That it can be an embarrassment, 
the way people go out of  their way to disguise it or hide it. And also [the] psychological impact, the frustration 
they might have, the embarrassment.” [PH1]
Greater treatment knowledge
Several commented on how they were unaware of  the importance of  emollient therapy but 
had	noticed	big	 improvements	 in	patients’	 condition	after	 recommending	emollient	use	as	one	
pharmacist explained:
“I think [I have a] much better knowledge of  how to manage it for patients and the importance of  emollient 
therapy as well as active treatments. I probably wasn’t fully aware of  quite how beneficial emollients can 
be to patients.... [I’d] talk to patients about using their Dovonex or their Dovobet [active treatments] but not 
about whether they’re using an emollient with it, whereas now it’s the first thing that I talk about…. [PH4]
Improved confidence
One pharmacist mentioned how the study had improved her confidence when discussing psoriasis 
with patients: 
“Now I feel a lot more confident when talking to a patient who suffers with psoriasis, about what it is, how 
to treat it, how to use the different treatments, I couldn’t have given proper advice before….” [PH5]
What did pharmacists enjoy most about participating in the study?
The key theme to emerge was the notion of  increased job satisfaction with three sub-themes:
•	Greater	patient	contact
•	Making	a	difference
•	Giving	patients	time
Pharmacists enjoyed the time spent with patients. It was perceived by most as a welcome 
opportunity to discuss the condition with patients, something that was clearly absent in previous 
encounters with healthcare professionals, as portrayed by one pharmacist:  
“The feedback I got from a lot of  them was that they’d been diagnosed with it [psoriasis] a long time ago 
and left to get on with it and probably didn’t ever have that sit down time with anyone since they first saw 
a dermatologist who diagnosed it 20 years ago and now they just muddle through and no one’s taking an 
active role. The patients certainly appreciated that time to talk through what they’re doing…” [PH4].
Making a difference 
A consequence of  spending more time with patients was the importance of  being able to make a 
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difference for patients. The follow-up consultation provided the prospect of  assessing the impact 
of 	their	advice	on	the	patient’s	condition	as	summed	up	by	one	pharmacist:	
“I certainly enjoyed meeting the patients and helping them because there’s a lot of  satisfaction you can gain 
from that … also just having the patient come back to you and having your clinical intervention assessed.” 
[PH3]
This was elaborated on by another, who gained satisfaction from being able to make a difference: 
“I think patients really gained a lot from it [the study] which I liked, spending that little bit of  extra time with 
someone talking [about] treatments, making sure that they know what formulation should be used and when 
and just helping them with all the basic things helped giving me a bit of  job satisfaction.” [PH2]
Giving patients time 
The importance of  spending sufficient time with patients was also seen as valuable by one 
pharmacist as many patients lacked very basic knowledge about their condition: 
“I think they were very grateful that someone had actually taken the time to sit down and talk to them about 
it because I don’t think many people had that intervention. Even one of  the ladies who really had quite bad 
psoriasis and had consulted at secondary care about it [in the past] and I don’t know what her care had 
been, but her understanding was probably one of  the worst.” [PH2]
What problems/difficulties did pharmacists encounter during the study?
A predominant theme to emerge was the concept of  research struggles for which there were three 
sub-themes:
•	Study	paperwork
•	Patient	engagement
•	 Juggling	with	other	work
Study paperwork
Few pharmacists mentioned any major difficulties undertaking the study though one, while 
accepting that documentation was a necessary burden, felt that this was something they disliked:
“Paperwork that was it [what they disliked]. But that’s something that any clinician would moan about but 
unfortunately at the end of  the day we have to record it so I understand that.” [PH3]
Two pharmacists had specific problems with the study paperwork. One, for instance, felt that the 
questionnaires, were difficult to follow:
“I didn’t like a lot of  the questionnaires, how they were defined, I felt they perhaps they weren’t very well 
phrased… I felt the questions weren’t formulated in a very accessible manner.” [PH7]
The other was unclear about how to calculate the SAPASI (disease severity) score, as he explained:
“The worst thing for me was probably the paperwork side. It was not always clear on the mathematics; I 
think the sheets weren’t very clear on the sums.” [PH1]
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Patient engagement
Identifying suitable study patients was problematic for one pharmacist as they explained: 
“For me it was probably just the population I’m dealing with, highlighting the right customers, either people 
weren’t coming in, they were sending somebody else in or perhaps they were under specialist care...” [PH1]
In addition, two of  the pharmacists highlighted the difficulties in getting patients to return for the 
follow-up appointment as one described: 
“For the second consultation one of  them was impossible to get in touch [with]. I think I rung maybe 10 
times and there was no answer and [for] two patients it took a few phone calls before I managed [to get] 
them to come back.” [PH5]
Another spoke of  his concerns about ensuring that patients returned within the specified time-
frame:
“We were trying to get them between 6 and 8 weeks post the first intervention but it wasn’t always that 
possible. I didn’t know really how that was going to impact on the study results if  I didn’t get them in on 
that times-scale.” [PH2]
Juggling with other work
A more practical difficulty for some was the fine balancing act required to consult with study 
patients and meeting the demands of  others as one explained: 
“As with anything in pharmacy, juggling the time taken to do it [the study], while you’re needing to catch up 
when you come back … you have to try and manage it in the day … so that you weren’t putting yourself  
behind for the rest of  the patients …” [PH4]
Though some pharmacists had arranged specific times for the follow-up appointment, the 
unpredictable nature of  the workload in the pharmacy created a degree of  anxiety for one 
pharmacists if  they were busy at the allotted time for a study patient:
“It’s like maybe there was [sic] patients waiting or the [study] patient came at a time where we were very busy. 
It’s just the stress of  knowing there are other people waiting for prescriptions.” [PH5]
How did pharmacists believe patients viewed their role as a result of  the study?
The main theme to emerge was the concept of  an augmented clinical role with sub-themes of:
•	 Information	providers
•	Members	of 	the	management	team
Information providers
There was a general consensus that patients benefited greatly from the study. Virtually all 
pharmacists described how at the initial consultation, few patients understood much about their 
condition, possible triggers and perhaps more importantly, how to use prescribed treatments. 
In some instances, pharmacists felt that their input, especially on the correct use of  treatments 
avoided	the	need	for	a	GP	appointment	as	summed	up	by	one:
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“A lot of  them [patients] had got the creams and didn’t understand how best to use them, in which order, 
how much, how often, that kind of  thing. They don’t understand that you can use it once or twice a day. 
We gave that education in getting the best out of  it [treatment] without having to go back to the GP.” [PH1]
This view was echoed by another who was surprised that emollient use by patients was low: 
“Some of  them didn’t even know that they had to use emollients and two of  them had never used [emollients] 
before. The difference was massive when they started using them. It was the knowledge about the treatment 
and how to use it [that] was very, very low and some patients had been suffering with psoriasis for many 
years.” [PH5]
One pharmacist identified a patient who had stopped using emollients and continued with his 
active treatment even though this was not effective: 
“He had a satisfactory level of  knowledge about how to use the steroid but his condition had never been 
brought under control in the first place, so the idea of  stopping therapy just sort of  never came into it. He 
had stopped using the emollients that the doctor prescribed initially because he didn’t perceive that they were 
of  any benefit, so I had to explain their role” [PH6] 
Members of  the management team
After the study, pharmacists believed that patients would now perceive them as a member of  the 
primary healthcare team looking after them. This view was, to some extent, re-enforced when 
pharmacists	proactively	recommended	treatment	changes	to	the	GP	as	one	described:
“I took the responsibility to contact their prescriber and gave a few suggestions of  emollients that they could 
prescribe and quantities that I would be expecting them to use. And the local prescribers did what I’d asked 
them, which was really empowering. And I think they really appreciated it.” [PH2]
One pharmacist commented on how patients continued to mention their psoriasis after the study 
finished: 
“There are patients from the study [who] still come in and let me know how their psoriasis is going now, 
several months later and they’re still feeding back that it’s improving, it’s still working well and so they 
definitely valued the input that was given to them.” [PH4]
Do pharmacists think the intervention could be rolled out nationally? 
There was no one overarching theme but several themes identified were:
•	Extension	to	MURs
•	Training	required
•	Viable	service
•	Unlikely	to	be	standalone	service
The question as to whether the intervention could be developed an enhanced service and more 
widely adopted in pharmacies, generated a mixed response. 
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Extension to MURs
Some felt that the intervention could be incorporated into existing services such as the MUR 
(Medicines use Review) as one pharmacist explained:
“Definitely [could become a national service] … the MURs are getting extended into other areas, the target 
groups are getting increased so it definitely seems like a sensible option to include that [the intervention] 
somewhere like that.” [PH1]
Another felt that it could become embedded within an MUR for a patient with psoriasis:
“I think it would make a good bolt on to an MUR, specifically added on to the end.  The regular business of  
the MUR done but now I’d like to take things a bit further, just use the last 10 minutes to do this questionnaire 
[PEDESI]”. [PH6]
Training required
While believing that the service could be more widely accepted, the need for further training was 
felt	to	be	obligatory	by	two	pharmacists	in	order	to	reassure	GPs	that	community	pharmacists	were	
providing the correct advice to patients as one outlined:
“Potentially [could be a national service] provided the GPs are aware that the pharmacies have had the 
training.” [PH6]
The importance of  training was reiterated by another pharmacist:
“I think the training [for the service] needs to be more solid, it must be able to give confidence to the 
pharmacists that they have done it the right way, have they said the right things, have they provided the right 
advice.” [PH7]
Viable service
One pharmacist was positive that the intervention could be rolled out nationally, especially as the 
few patients she recruited had such a poor understanding of  how to use treatments:
“If  it was treated as an enhanced service that every pharmacy in the United Kingdom could do that would 
be great. I’ve seen only 7 patients but after what I’ve seen about how little they know about the treatment 
and how to use it, what about all the other patients who go to other pharmacies … It couldn’t be just the few 
people who are doing the study, it could be everywhere.” [PH5]
Unlikely to be standalone service
In contrast, another pharmacist was more circumspect about whether an intervention focusing 
purely on psoriasis would be able to attract any funding even though the concept of  pharmacists 
helping patients with long-term conditions was of  value:
“I think there’s definitely scope for us to manage those kind of  long-term conditions where it would need 
careful management. Because it’s such a small patient group, it would be difficult to skill up and deliver 
that service for just your own population… the remuneration would be skewed too far out to warrant the 
funding. But if  you could have different pharmacies specializing in different things that you refer to each 
other locally, I think that might be a better model.” [PH4]
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discussion
Main findings
The main findings of  this study are that patients with psoriasis valued the educational input provided 
during consultations with community pharmacists and believed that this enhanced knowledge 
improved their skin condition. This perception was echoed by pharmacists who also felt that the 
intervention boosted their level of  job satisfaction and engendered the belief  that they made a 
significant contribution to patient care. 
The fact that most patients expressed the desire for information on psoriasis and its management 
was somewhat surprising given that on average, patients had suffered with the condition for 24 
years. Nevertheless, the demand for more advice on psoriasis, associated triggers, co-morbidity 
and prognosis has been identified in previous work19 and as illustrated in Table 2 this request was 
one of  the central benefits derived from the pharmacist consultations, signifying that they were 
able to fulfil an unmet need.
Despite the potential benefits to patients, interviews with some of  the pharmacists implied that 
wider adoption of  the service might be more difficult. The unpredictable nature of  the workload in 
pharmacies combined with the small number of  those with psoriasis per pharmacy were possible 
stumbling blocks to the commissioning of  such a service. Although pharmacists were able to 
embrace the service alongside their existing workload, if  such an intervention be implemented 
among the wider pharmacy community, commissioners should learn the lessons encountered 
with other services. For example, one recent examination of  the new medicine service advocated 
engagement with all relevant stakeholders as well as more robust planning to ensure an effective 
national roll-out of  the service20.
The major strength of  this study is that it appears to be the first exploration of  the role of  pharmacists 
in helping patients with psoriasis and as such adds to the limited body of  information that is currently 
available on this topic. It also highlights the feasibility of  delivering an educational intervention in 
pharmacies for such patients. The perception of  benefit among patients is an important finding 
because as described by Ersser7 and Nelson8, irregular use of  topical therapies by patients 
was partly related to insufficient knowledge of  the beneficial therapeutic effects achieved from 
consistent use of  treatment. Nevertheless, the study does have some recognized limitations. The 
unavoidable use of  a convenience patient sample meant that the problem of  non-respondent bias 
could not be examined in any detail. Furthermore, the single follow-up meant that we were unable 
to determine the longer-term impact of  the educational advice on disease severity. In addition, the 
small number of  participating pharmacists curtailed a more comprehensive exploration of  views 
on the acceptability and potential benefits of  the intervention. 
An aspiration of  Pharmacy in England15 is that pharmacists expand and improve the range of  
clinical services they offer, especially to those with long term conditions such as psoriasis. The 
present study implies that educational advice from pharmacists goes some way towards addressing 
patients’	needs.	  
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conclusion
This study revealed that patients with psoriasis perceived a benefit from an educational intervention 
by community pharmacists, who welcomed the opportunity for greater patient interaction, enabling 
them to make an important contribution to patient care. Whether the intervention could be added 
to the range of  existing clinical services in pharmacy requires further investigation. In order to 
establish more clearly the role of  pharmacists in the care of  those with psoriasis, future studies 
need to explore whether the reported benefits observed are sustained over the longer-term and are 
greater than those that might be expected from standard care. 
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